Drug Approval | November 01, 2023
Lupin Mandideep plant gets USFDA green signal
The inspection of the facility conducted from August 7 to August 11, 2023
The inspection of the facility conducted from August 7 to August 11, 2023
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
Additional premium services in RegXcellence will include access to BASF’s Product Carbon Footprint data and direct downloads of audit reports
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Evonik China and Shandong Vland Biotech agreed to build a joint venture to expand their presence in gut health solutions products for farm animals globally
The USFDA inspectors issued the observations after a product pre-approval inspection of the biologics facility in Bachupally
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
Subscribe To Our Newsletter & Stay Updated
